22-Apr-2022 | Facts and Factors
The global in vitro fertilization (IVF) market was worth around USD 628.50 million in 2021 and is estimated to grow to about USD 1,036.7 million by 2028, with a compound annual growth rate (CAGR) of approximately 8.7% over the forecast period. The report analyzes the in vitro fertilization (IVF) market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the in vitro fertilization (IVF) market.
In vitro fertilization (IVF) has gained massive popularity in the past few years and its use in treating fertility issues among the population has increased this trend is expected to be prominent over the forecast period as well. Increasing cases of infertility and rising demand for reproductive technology will also boost in vitro fertilization (IVF) market potential over the forecast period.
Browse the full “In Vitro Fertilization (IVF) Market By Type (Conventional IVF, IVF with ICSI, IVF with Donar Eggs, Others), By Cycle (Fresh Non-donor IVF Cycles, Frozen Non-donor IVF Cycles, Frozen Donor IVF Cycles, Fresh Donor IVF Cycle), By Product (Equipment, Sperm Analyzer Systems, Imaging Systems, Ovum Aspiration Pumps, Micromanipulator Systems, Incubators, Gas Analyzers, Laser Systems, Cryosystems, Sperm Separation Devices, IVF Cabinets, Anti-vibration Tables, Witness Systems, Other Equipment, Reagents & Media, Cryopreservation Media, Embryo Culture Media, Ovum Processing Media, Sperm Processing Media, Accessories), By End User (Fertility Clinics, Hospitals & Surgical Centers, Cryobanks, Research Institutes), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecast 2022 – 2028” report at https://www.fnfresearch.com/in-vitro-fertilization-market
In vitro fertilization (IVF) procedures are seeing an increase in multiple regions owing to rising the availability and popularity of them. Supportive government initiatives to boost the establishment of fertility clinics will also propel in vitro fertilization (IVF) market growth through 2028. Increasing medical tourism across the world will also positively impact the in vitro fertilization (IVF) market potential.
However, the high costs associated with in vitro fertilization (IVF) procedures will act as a restraining factor for the in vitro fertilization (IVF) market potential and the expected to follow the same trend through 2028.
The COVID-19 pandemic resulted in shuttering of multiple fertility clinics and induced a major negative trend for the in vitro fertilization (IVF) market. Lockdown restrictions resulted in a drop in vitro fertilization (IVF) procedures and also had a negative impact on the upcoming surgeries which were canceled by couples due to economic and social stability in the world in the pandemic era.
Strict lockdown regulations caused the closure of multiple IVF clinics and this led to a major drop in IVF procedures performed across the world but this is expected to change in the post-pandemic era as the world returns to normal and fertility clinics open with full access to people and return of economic stability.
The global in vitro fertilization (IVF) market is segregated based on type, product, cycle, end-user, and region. Based on cycle, the global market is distinguished into Fresh Non-donor IVF Cycles, Frozen Non-donor IVF Cycles, Frozen Donor IVF Cycles, Fresh Donor IVF Cycle. The technical textile sub-segment is anticipated. The fresh non-donor segment is anticipated to account for a major market share and is projected to be a dominant segment through the forecast period. high success rates and ease in the implantation process are major factors favoring the growth of this segment and boosting in vitro fertilization (IVF) market growth potential through 2028.
The market for in vitro fertilization (IVF) in the Asia Pacific region will see a dominant outlook over the forecast period and will majorly be driven by the rising number of in vitro fertilization (IVF) procedures in this region. The rise in demand for in vitro fertilization (IVF) in this region will also be driven by supportive government initiatives, an increasing number of fertility clinics, rising availability, and popularity of in vitro fertilization (IVF) procedures, etc. India and China are anticipated to be highly lucrative markets for in vitro fertilization (IVF) companies owing to the high population and rising medical tourism in these nations.
Report Scope
Report Attribute |
Details |
Market Size in 2021 |
USD 628.50 Million |
Projected Market Size in 2028 |
USD 1,036.7 Million |
CAGR Growth Rate |
8.7% CAGR |
Base Year |
2021 |
Forecast Years |
2022-2028 |
Key Market Players |
The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Rocket Medical plc (UK), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), FERTIPRO NV(Belgium), and Gynotec B.V. (Netherlands), among others |
Key Segment |
By Type, Cycle, Product, End-User, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Key players functioning in the global in vitro fertilization (IVF) market include The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Rocket Medical plc (UK), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), FERTIPRO NV(Belgium), and Gynotec B.V. (Netherlands).
Recent developments:
- In 2021, Hamilton Thorne Ltd. a leading provider of precision instruments announced that it got the FDA approval for the commercialization of its new ready to use medium by GYNEMED GM501 that will be used to wash human oocytes and embryos for in vitro fertilization (IVF) procedures in the United States and Europe regions.
The Global in vitro fertilization (IVF) market is segmented as follows:
By Type
- Conventional IVF
- IVF with ICSI
- IVF with Donar Eggs
- Others
By Cycle
- Fresh Non-donor IVF Cycles
- Frozen Non-donor IVF Cycles
- Frozen Donor IVF Cycles
- Fresh Donor IVF Cycle
By Product
- Equipment
- Sperm Analyzer Systems
- Imaging Systems
- Ovum Aspiration Pumps
- Micromanipulator Systems
- Incubators
- Gas Analyzers
- Laser Systems
- Cryosystems
- Sperm Separation Devices
- IVF Cabinets
- Anti-vibration Tables
- Witness Systems
- Other Equipment
- Reagents & Media
- Cryopreservation Media
- Embryo Culture Media
- Ovum Processing Media
- Sperm Processing Media
- Accessories
By End-User
- Fertility Clinics
- Hospitals & Surgical Centers
- Cryobanks
- Research Institutes
By Region
- North America
- The U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Reunion
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A - 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
